Glycoconjugates: synthesis, functional studies, and therapeutic developments

SS Shivatare, VS Shivatare, CH Wong - Chemical reviews, 2022 - ACS Publications
Glycoconjugates are major constituents of mammalian cells that are formed via covalent
conjugation of carbohydrates to other biomolecules like proteins and lipids and often …

Human dendritic cells: their heterogeneity and clinical application potential in cancer immunotherapy

TA Patente, MP Pinho, AA Oliveira… - Frontiers in …, 2019 - frontiersin.org
Dendritic cells (DC) are professional antigen presenting cells, uniquely able to induce naïve
T cell activation and effector differentiation. They are, likewise, involved in the induction and …

Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want

H HogenEsch, DT O'Hagan, CB Fox - npj Vaccines, 2018 - nature.com
Aluminum-containing adjuvants have been used for over 90 years to enhance the immune
response to vaccines. Recent work has significantly advanced our understanding of the …

[HTML][HTML] The health effects of aluminum exposure

K Klotz, W Weistenhöfer, F Neff, A Hartwig… - Deutsches Ärzteblatt …, 2017 - ncbi.nlm.nih.gov
Background Aluminum is regularly taken up with the daily diet. It is also used in
antiperspirants, as an adjuvant for vaccination, and in desensitization procedures. In this …

Nanocarrier vaccines for SARS-CoV-2

J Machhi, F Shahjin, S Das, M Patel… - Advanced Drug Delivery …, 2021 - Elsevier
The SARS-CoV-2 global pandemic has seen rapid spread, disease morbidities and death
associated with substantive social, economic and societal impacts. Treatments rely on re …

Vaccine technologies: From whole organisms to rationally designed protein assemblies

CP Karch, P Burkhard - Biochemical pharmacology, 2016 - Elsevier
Vaccines have been the single most significant advancement in public health, preventing
morbidity and mortality in millions of people annually. Vaccine development has traditionally …

Biomaterials for vaccine-based cancer immunotherapy

R Zhang, MM Billingsley, MJ Mitchell - Journal of Controlled Release, 2018 - Elsevier
The development of therapeutic cancer vaccines as a means to generate immune reactivity
against tumors has been explored since the early discovery of tumor-specific antigens by …

Developments in vaccine adjuvants

FZ Firdaus, M Skwarczynski, I Toth - Vaccine Design: Methods and …, 2022 - Springer
Vaccines, including subunit, recombinant, and conjugate vaccines, require the use of an
immunostimulator/adjuvant for maximum efficacy. Adjuvants not only enhance the strength …

[PDF][PDF] NOD-like receptors in infection, immunity, and diseases

YK Kim, JS Shin, MH Nahm - Yonsei medical journal, 2016 - synapse.koreamed.org
Nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) are pattern-
recognition receptors similar to toll-like receptors (TLRs). While TLRs are transmembrane …

[PDF][PDF] Recent advances of vaccine adjuvants for infectious diseases

S Lee, MT Nguyen - Immune network, 2015 - synapse.koreamed.org
Vaccines are the most effective and cost-efficient method for preventing diseases caused by
infectious pathogens. Despite the great success of vaccines, development of safe and strong …